To hear about similar clinical trials, please enter your email below
Trial Title:
Molecular Markers in Cervical Cancer Screening in the Feasibility of the Mathematical Markov Model Analysis
NCT ID:
NCT00889902
Condition:
Cervical Cancer
Conditions: Official terms:
Uterine Cervical Neoplasms
Conditions: Keywords:
Molecular Markers
Cervical Cancer
Screening
Makov
Study type:
Observational
Overall status:
Unknown status
Study design:
Time perspective:
Prospective
Summary:
The purpose of this study is to:
1. make p16INK4A as a cervical cancer screening of tumor markers, cytology improve
existing diagnostic sensitivity, specificity, repeatability and validity, so as to
effectively prompted the early discovery and diagnosis of cervical cancer.
2. reduce screening costs, screening and benefits into quantitative evaluation, for our
country to develop cervical cancer prevention and control strategy to provide a
reliable theoretical basis.
Detailed description:
1. To carry out large-scale prospective randomized controlled clinical study to
evaluate the "cytological molecular markers Detect + P16INK4A" methods of screening
accuracy and reliability, as well as the screening method of the biological effects.
2. Markov set up mathematical model of screening tests to quantify the inputs and the
evaluation proceeds. With a view to optimize and perfect a simple, convenient,
practical and efficient program of cervical cancer screening.
Criteria for eligibility:
Study pop:
residents of a certain town
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Married women aged 25 to 65-year-old with risk factors
- No tumor and pelvic radiation therapy history
- Non-pregnant women at present
Gender:
Female
Minimum age:
25 Years
Maximum age:
65 Years
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
People'S Hospital
Address:
City:
Wufeng county
Country:
China
Start date:
April 2009
Completion date:
July 2011
Lead sponsor:
Agency:
Wuhan University
Agency class:
Other
Source:
Wuhan University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT00889902
